21 CFR §660.44
Verified against eCFR.gov as of June 20, 2026View official text on eCFR.gov ↗
Each filling of the product shall be specific for Hepatitis B Surface Antigen as determined by specificity tests found acceptable to the Director, Center for Biologics Evaluation and Research.